Propofol for treatment resistant depression: A randomized controlled trial

Scott C. Tadler, Keith G. Jones, Carter Lybbert, Jason C. Huang, Rana Jawish, Daniela Solzbacher, E. Jeremy Kendrick, Matthew D. Pierson, Kamile Weischedel, Noreen Rana, Rebecca Jacobs, Lily C. Vonesh, Daniel A. Feldman, Claire Larson, Nathan Hoffman, Jacob E. Jessop, Adam L. Larson, Norman E. Taylor, David H. Odell, Kai Kuck, Brian J. Mickey
doi: https://doi.org/10.1101/2023.09.12.23294678

Article usage

Article usage: September 2023 to May 2025

AbstractFullPdf
Sep 2023375999
Oct 20231711177
Nov 2023120434
Dec 202351222
Jan 202452122
Feb 202468242
Mar 202492254
Apr 202443723
May 202488740
Jun 202467128
Jul 202481452
Aug 202477351
Sep 202468439
Oct 202477639
Nov 202461129
Dec 202474038
Jan 202551241
Feb 2025682755
Mar 20251252764
Apr 20251131666
May 2025621454
Back to top
Posted September 15, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Propofol for treatment resistant depression: A randomized controlled trial
Scott C. Tadler, Keith G. Jones, Carter Lybbert, Jason C. Huang, Rana Jawish, Daniela Solzbacher, E. Jeremy Kendrick, Matthew D. Pierson, Kamile Weischedel, Noreen Rana, Rebecca Jacobs, Lily C. Vonesh, Daniel A. Feldman, Claire Larson, Nathan Hoffman, Jacob E. Jessop, Adam L. Larson, Norman E. Taylor, David H. Odell, Kai Kuck, Brian J. Mickey
medRxiv 2023.09.12.23294678; doi: https://doi.org/10.1101/2023.09.12.23294678
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area